---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-020163"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2023-06-06T23:59:59+00:00"
generated_at: "2026-06-14T06:26:01.170632+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology Holdings effects 1-for-10 reverse stock split

## Summary
- Reverse stock split effective June 2, 2023; every 10 shares combined into 1.
- Stockholders approved the split at a Special Meeting on May 26, 2023.
- Common stock begins trading on Nasdaq on a split-adjusted basis June 5, 2023.
- No fractional shares issued; any fractional share rounded up to nearest whole share.
- Proportionate adjustments made to options, warrants, and Series A Preferred conversion.

## SEC filing metadata
- accession: 0001493152-23-020163
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2023-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315223020163/0001493152-23-020163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315223020163/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-020163
- JSON: https://secwatch.observer/filing/0001493152-23-020163.json
- Plain text: https://secwatch.observer/filing/0001493152-23-020163.txt

## Key facts
- Governance Changes
  LIXTE BIOTECHNOLOGY HOLDINGS, INC.: Filed a Certificate of Amendment to the Certificate of Incorporation to effect a 1-for-10 reverse stock split of common stock, effective June 2, 2023 (effective 2023-06-02).
  - Change: charter amendment
  - Effective: 2023-06-02
  source text: On June 1, 2023, Lixte Biotechnology Holdings, Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of its outstanding shares of common stock. The Amendment was effective on June 2, 2023 (the “Effective Time”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1335105/000149315223020163/0001493152-23-020163-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.